Prevalence of remission of type 2 diabetes in a real-world cohort: An analysis of the National Diabetes Audit in England and Wales

被引:0
|
作者
Holman, N. [1 ]
Curley, M. [2 ]
Valabhji, J. [3 ]
Barron, E. [4 ]
Knighton, P. [2 ]
Young, B. [2 ]
机构
[1] Univ Glasgow, Inst Cardiovasc & Med Sci, Glasgow, Lanark, Scotland
[2] NHS Digital, Clin Audits & Registries Management Serv, Leeds, W Yorkshire, England
[3] Imperial Coll Healthcare NHS Trust, Dept Med, London, England
[4] Publ Hlth England, Natl Cardiovasc Intelligence Network, York, N Yorkshire, England
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P514
引用
收藏
页码:180 / 180
页数:1
相关论文
共 50 条
  • [21] Real-world study of flash glucose monitoring among adults with type 2 diabetes within the Swedish National Diabetes Register
    Eeg-Olofsson, Katarina
    Svensson, Ann-Marie
    Franzen, Stefan
    Ismail, Hodan Ahmed
    Tornblom, Michael
    Levrat-Guillen, Fleur
    [J]. DIABETES & VASCULAR DISEASE RESEARCH, 2022, 19 (01):
  • [22] Type 1 diabetes: analysis of real-world insulin injection patterns
    Catrina, S.
    Hartvig, N.
    Kaas, A.
    Moller, J.
    Mardby, A. -C.
    Jendle, J.
    [J]. DIABETOLOGIA, 2020, 63 (SUPPL 1) : S378 - S378
  • [23] Eligibility and Awareness Regarding Metabolic Surgery in Patients With Type 2 Diabetes Mellitus in the Real-World Clinical Setting; Estimate of Possible Diabetes Remission
    Koliaki, Chrysi
    Tzeravini, Evangelia
    Papachristoforou, Eleftheria
    Severi, Ioanna
    El Deik, Elina
    Karaolia, Melina
    Noutsou, Marina
    Thanopoulou, Anastasia
    Kountouri, Aikaterini
    Balampanis, Konstantinos
    Lambadiari, Vaia
    Tentolouris, Nicholas
    Kokkinos, Alexander
    [J]. FRONTIERS IN ENDOCRINOLOGY, 2020, 11
  • [24] REAL-WORLD EFFECTIVENESS OF IGLARLIXI THERAPY IN OUTPATIENTS WITH TYPE 2 DIABETES: THE SOLO RETROSPECTIVE COHORT STUDY
    Antsiferov, M.
    Demidov, N.
    Balberova, M.
    Safronova, T.
    Mishra, O.
    Magomedova, S.
    [J]. DIABETES TECHNOLOGY & THERAPEUTICS, 2022, 24 : A177 - A178
  • [25] Real-world efficacy data in patients with type 2 diabetes on Semaglutide
    Zitterl, Andreas
    Peric, Slobodan
    Pichler, Maximilian
    Prager, Margarete
    Prager, Rudolf
    Stulnig, Thomas
    [J]. WIENER KLINISCHE WOCHENSCHRIFT, 2022, 134 (SUPPL 4) : 265 - 265
  • [26] Elderly Latino Patients with Type 2 Diabetes: A Real-World Perspective
    Cagide, Ana L.
    Giunta, Diego H.
    Bader, Giovanni
    Paldanius, Paivi M.
    Mendivil, Carlos O.
    [J]. DIABETES, 2016, 65 : A289 - A289
  • [27] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Louise A. Donnelly
    Kaixin Zhou
    Alex S. F. Doney
    Chris Jennison
    Paul W. Franks
    Ewan R. Pearson
    [J]. Diabetologia, 2018, 61 : 607 - 615
  • [28] Rates of glycaemic deterioration in a real-world population with type 2 diabetes
    Donnelly, Louise A.
    Zhou, Kaixin
    Doney, Alex S. F.
    Jennison, Chris
    Franks, Paul W.
    Pearson, Ewan R.
    [J]. DIABETOLOGIA, 2018, 61 (03) : 607 - 615
  • [29] Liraglutide and cardiovascular outcomes in a real world type 2 diabetes cohort
    Mirani, Marco
    Favacchio, Giuseppe
    Serone, Eliseo
    Lucisano, Giuseppe
    Rossi, Maria Chiara
    Berra, Cesare C.
    [J]. PHARMACOLOGICAL RESEARCH, 2018, 137 : 270 - 279
  • [30] Understanding the Prevalence of Prediabetes and Diabetes in Patients With Cancer in Clinical Practice: A Real-World Cohort Study
    Ose, Dominik J.
    Viskochil, Richard
    Holowatyj, Andreana N.
    Larson, Mikaela
    Wilson, Dalton
    Dunson, William A., Jr.
    Deshmukh, Vikrant G.
    Butcher, J. Ryan
    Taylor, Belinda R.
    Svoboda, Kim
    Leiser, Jennifer
    Tingey, Benjamin
    Haaland, Benjamin
    Wetter, David W.
    Fisher, Simon J.
    Hashibe, Mia
    Ulrich, Cornelia M.
    [J]. JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2021, 19 (06): : 709 - +